SPECIAL SELECTED TOPICS- RESPIRATORY SYSTEM DISORDERS-SSTRSDO-QAA 012

 1. Discuss the main pathologic characteristics of primary tuberculosis.

Primary tuberculosis develops in individuals not previously exposed to Mycobacterium tuberculosis. The primary lesion, called the Ghon focus, usually forms in the subpleural region of the lower part of the upper lobe or the upper part of the lower lobe.

The bacilli spread through lymphatics to the hilar lymph nodes. The combination of the Ghon focus and involved hilar lymph nodes constitutes the Ghon complex.

Histologically, granulomas composed of epithelioid cells, Langhans giant cells, and lymphocytes surround central caseous necrosis. Fibrosis and calcification commonly occur during healing.

Most primary infections are asymptomatic and heal spontaneously. In immunocompromised individuals, progressive primary tuberculosis may develop with extensive pulmonary and systemic disease.

2. What are the main pathologic characteristics of secondary pulmonary tuberculosis and tuberculous bronchopneumonia?

Secondary pulmonary tuberculosis develops in previously sensitized individuals due to reactivation or reinfection with Mycobacterium tuberculosis.

The lesions usually involve the apical segments of the upper lobes where oxygen tension is highest. Caseating granulomas with central necrosis are the characteristic pathological feature. Progressive disease leads to cavitation caused by liquefaction of caseous material. Fibrosis and calcification are common in healing lesions.

Tuberculous bronchopneumonia occurs when infected material spreads through the bronchi to adjacent lung tissue. Numerous patchy areas of caseating consolidation develop throughout the lungs.

Extensive pulmonary destruction may lead to respiratory failure. Hematogenous spread may result in miliary tuberculosis. Untreated disease may become chronic and highly infectious.

3. Define miliary tuberculosis and tuberculous bronchopneumonia.

Miliary tuberculosis is a disseminated form of tuberculosis resulting from hematogenous spread of Mycobacterium tuberculosis. Numerous tiny millet seed-sized granulomas develop simultaneously in the lungs and other organs.

Commonly affected organs include the liver, spleen, kidneys, bone marrow, meninges, and adrenal glands. It is a life-threatening condition requiring prompt diagnosis and treatment. Tuberculous bronchopneumonia develops when tuberculous material spreads through the bronchial tree. Multiple patchy foci of caseating inflammation appear in different parts of the lungs.

 The lesions resemble bronchopneumonia but contain tuberculous granulomas. Patients usually have fever, cough, and progressive respiratory symptoms.

Both conditions indicate active and widespread tuberculosis. Early antitubercular therapy significantly improves prognosis.

4. Which histologic and laboratory methods are useful in the diagnosis of tuberculosis?

Histologically, tuberculosis is identified by caseating granulomas composed of epithelioid histiocytes, Langhans giant cells, lymphocytes, and central caseous necrosis. Ziehl–Neelsen staining demonstrates acid-fast bacilli within tissue or sputum.

Auramine-rhodamine fluorescent staining increases detection sensitivity. Sputum smear microscopy remains a widely used diagnostic method. Mycobacterial culture is the gold standard for confirming infection and determining drug susceptibility.

Nucleic acid amplification tests, such as GeneXpert MTB/RIF, rapidly detect tuberculosis and rifampicin resistance. Tuberculin skin testing and interferon-gamma release assays identify prior exposure. Chest radiography and CT scanning demonstrate characteristic pulmonary lesions.

Histopathology combined with microbiological confirmation establishes the diagnosis. Molecular techniques have greatly improved early detection.

---

DR.C.GANESAN M.D

PROFESSOR OF MEDICINE

 

SPECIAL SELECTED TOPICS- RESPIRATORY SYSTEM DISORDERS-SSTRSDO-QAA 028

1. What are the main characteristics of bronchogenic carcinomas?

Bronchogenic carcinoma is the most common primary malignant tumor of the lung and a leading cause of cancer-related death worldwide. Most cases are strongly associated with cigarette smoking. The tumor usually arises from the bronchial epithelium after progressive dysplastic and malignant transformation.

Bronchogenic carcinomas are aggressive tumors with early local invasion and distant metastasis. Patients commonly present with cough, hemoptysis, chest pain, dyspnea, or recurrent pneumonia. Some tumors produce paraneoplastic syndromes due to ectopic hormone secretion. Histologically, they are classified into several major subtypes.

Early diagnosis is often difficult because symptoms appear late. Prognosis depends mainly on histological type and clinical stage.

2. Which etiologic agents have been known to promote lung cancers?

Cigarette smoking is the single most important etiological factor responsible for lung cancer. Passive smoking also increases the risk. Occupational exposure to asbestos, arsenic, chromium, nickel, beryllium, and uranium contributes significantly. Radon gas exposure is an important cause, especially in underground miners and poorly ventilated buildings.

Air pollution and diesel exhaust increase the incidence of lung cancer. Previous pulmonary fibrosis and chronic lung disease predispose to malignant transformation. Ionizing radiation is another recognized carcinogenic factor.

Genetic susceptibility influences individual risk. Smoking combined with asbestos exposure produces a synergistic increase in lung cancer risk.

Avoidance of tobacco remains the most effective preventive measure.

3. List the main histologic types of bronchogenic carcinomas.

Bronchogenic carcinomas are classified into four major histological types. Squamous cell carcinoma arises from bronchial epithelium and often shows keratinization. Adenocarcinoma originates from gland-forming epithelial cells and is the most common type overall.

Small cell carcinoma is a highly malignant neuroendocrine tumor with early metastasis. Large cell carcinoma is an undifferentiated malignant epithelial tumor lacking features of the other types.

Additional less common variants include adenosquamous carcinoma and sarcomatoid carcinoma. Histological classification guides treatment decisions.

Molecular testing is especially important in adenocarcinoma. Accurate pathological diagnosis is essential for prognosis and therapy.

 

4. What is the most common histologic type of lung cancer?

Adenocarcinoma is currently the most common histologic type of lung cancer worldwide. It occurs in both smokers and non-smokers but is particularly common among non-smokers and women. The tumor usually arises in the peripheral parts of the lung.

Histologically, it forms glands or produces mucin. Many tumors harbor mutations involving EGFR, ALK, KRAS, or other molecular pathways. Molecular testing is essential because targeted therapy improves survival in selected patients.

Adenocarcinoma may invade the pleura and metastasize early. Clinical presentation includes cough, dyspnea, chest pain, or incidental radiological detection.

Prognosis depends primarily on tumor stage at diagnosis.

5. How are lung cancers divided according to their response to chemotherapy?

Lung cancers are broadly divided into small cell lung carcinoma (SCLC) and non-small cell lung carcinoma (NSCLC) according to their biological behavior and response to treatment. Small cell carcinoma responds well initially to chemotherapy and radiotherapy because of its high mitotic activity.

However, recurrence is common, and long-term survival remains poor. Non-small cell carcinomas include squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. These tumors respond less effectively to chemotherapy than small cell carcinoma.

Surgical resection is the preferred treatment for localized NSCLC. Targeted therapy and immunotherapy have significantly improved outcomes in selected patients.

Accurate classification is essential for choosing appropriate treatment.

6. Which types of carcinomas are most closely related to smoking?

Squamous cell carcinoma and small cell carcinoma show the strongest association with cigarette smoking. Nearly all patients with small cell carcinoma have a significant smoking history.

Squamous cell carcinoma develops through squamous metaplasia and dysplasia induced by tobacco smoke. Large cell carcinoma also has a strong association with smoking. Adenocarcinoma is associated with smoking but also commonly occurs in non-smokers.

Tobacco smoke contains numerous carcinogens that produce genetic mutations in bronchial epithelial cells. The risk increases with the duration and intensity of smoking.

Smoking cessation substantially reduces future cancer risk. Tobacco control remains the most effective preventive strategy.

7. In which parts of the lung do most bronchogenic carcinomas arise?

The site of origin varies according to the histological subtype of bronchogenic carcinoma. Squamous cell carcinoma usually arises centrally in the main, lobar, or segmental bronchi. Small cell carcinoma also commonly originates in the central bronchi.

Adenocarcinoma most frequently develops in the peripheral lung parenchyma, often near the pleura. Large cell carcinoma may arise either centrally or peripherally. Peripheral tumors may invade the pleura and chest wall.

Central tumors commonly produce bronchial obstruction, atelectasis, and recurrent pneumonia. Knowledge of tumor location assists radiological diagnosis and biopsy planning.

Tumor site also influences clinical presentation and surgical management.

8. Describe the most common pathways of lung cancer spread.

Lung carcinoma spreads by direct invasion, lymphatic dissemination, hematogenous metastasis, and transcoelomic extension. Direct invasion involves the pleura, chest wall, mediastinum, diaphragm, or pericardium. Lymphatic spread first involves hilar and mediastinal lymph nodes.

Hematogenous spread commonly affects the brain, liver, adrenal glands, bones, and opposite lung. Pleural involvement may produce malignant pleural effusion.

Tumor cells may invade major blood vessels and bronchi. Small cell carcinoma metastasizes particularly early and extensively. Distant metastases are often present at the time of diagnosis. The extent of metastatic spread is a major determinant of prognosis.

9. What are the main pathologic features of squamous cell carcinoma of the lung?

Squamous cell carcinoma usually arises centrally from the major bronchi and is strongly associated with cigarette smoking. It develops through a sequence of squamous metaplasia, dysplasia, carcinoma in situ, and invasive carcinoma.

Grossly, the tumor forms a firm gray-white mass that may obstruct the bronchial lumen. Central necrosis frequently produces cavitation. Microscopically, malignant squamous cells show keratinization and intercellular bridges.

Tumor differentiation varies from well differentiated to poorly differentiated forms. Local invasion commonly involves adjacent bronchi and mediastinal structures.

Hypercalcemia may occur due to ectopic production of parathyroid hormone-related peptide (PTHrP). Surgical resection offers the best outcome in localized disease.

10. What are the main pathologic features of adenocarcinoma of the lung?

Adenocarcinoma is the most common primary lung cancer and usually arises in the peripheral lung parenchyma. It originates from glandular epithelial cells or type II pneumocytes. Grossly, it appears as a firm gray-white peripheral mass, often associated with pleural retraction.

Microscopically, the tumor forms glands or produces intracellular or extracellular mucin. Several histological patterns, including acinar, papillary, micropapillary, solid, and lepidic, may be present.

Molecular abnormalities involving EGFR, ALK, ROS1, and KRAS are common. The tumor invades pleura, lymphatics, and blood vessels in advanced stages. Regional lymph node and distant metastases may occur early.

Histological subtype and molecular profile guide targeted therapy and prognosis.

11. What are the main morphologic characteristics of bronchioloalveolar carcinoma?

Bronchioloalveolar carcinoma is now classified as adenocarcinoma in situ or lepidic-predominant adenocarcinoma. The tumor usually arises in the peripheral lung and may appear as a solitary nodule or diffuse pneumonic-type consolidation.

Microscopically, neoplastic cells grow along intact alveolar septa in a lepidic pattern without destroying the underlying lung architecture in early lesions. Mucin-producing and non-mucinous variants are recognized.

Stromal, vascular, and pleural invasion are absent in adenocarcinoma in situ but appear in invasive forms. Multiple bilateral lesions may occur. The surrounding alveolar framework is initially preserved.

Prognosis is excellent for non-invasive lesions after complete surgical excision. Invasive lesions behave like conventional adenocarcinoma.

12. Discuss the clinical symptoms caused by bronchioloalveolar carcinoma.

Patients commonly present with persistent cough and gradually progressive dyspnea. Copious watery sputum (bronchorrhea) is a characteristic feature in mucinous tumors. Hemoptysis may occur but is usually mild.

Chest pain is uncommon unless pleural invasion develops. Fever may lead to confusion with pneumonia. Weight loss and fatigue occur in advanced disease. Chest radiographs may show a solitary peripheral nodule or diffuse infiltrative shadows resembling pneumonia.

The tumor often responds poorly to antibiotics because it mimics infection. Early diagnosis depends on imaging, bronchoscopy, biopsy, and histopathological examination.

Prognosis is favorable in localized adenocarcinoma in situ but less favorable in diffuse invasive disease.

13. What are the main pathologic features of small cell carcinoma of the lung?

Small cell carcinoma is a highly malignant neuroendocrine tumor strongly associated with cigarette smoking. It usually arises centrally near the main bronchi. Grossly, it forms a soft gray-white infiltrative mass with extensive necrosis.

Microscopically, the tumor consists of small round or spindle-shaped cells with scant cytoplasm, finely granular chromatin, and numerous mitotic figures. Nuclear molding is a characteristic feature.

The tumor shows extensive vascular invasion and early metastasis. Neuroendocrine markers such as chromogranin, synaptophysin, and CD56 are typically positive. Ectopic hormone production commonly causes paraneoplastic syndromes.

sBecause dissemination occurs early, surgery is rarely useful, and chemotherapy with radiotherapy is the primary treatment.

14. Discuss the origin of large cell carcinoma of the lung.

Large cell carcinoma is an undifferentiated malignant epithelial tumor that lacks the histological features of squamous cell carcinoma, adenocarcinoma, or small cell carcinoma. It probably arises from primitive bronchial epithelial stem cells capable of multidirectional differentiation.

The tumor may occur in either central or peripheral parts of the lung. Grossly, it forms a large soft mass with areas of hemorrhage and necrosis. Microscopically, it contains large pleomorphic cells with abundant cytoplasm, prominent nucleoli, and frequent mitoses. Gland formation and keratinization are absent.

SThe tumor grows rapidly and metastasizes early. Prognosis is generally poor because most patients present with advanced disease. Treatment follows the principles used for non-small cell lung carcinoma.

15. How do lung carcinomas present clinically?

Lung carcinoma often remains asymptomatic during its early stages. Persistent cough is the most common presenting symptom. Hemoptysis, chest pain, dyspnea, and recurrent pneumonia occur because of airway obstruction or local invasion.

Constitutional symptoms include weight loss, anorexia, fatigue, and fever. Hoarseness results from recurrent laryngeal nerve involvement. Superior vena cava obstruction causes facial swelling and venous congestion. Pancoast tumors produce shoulder pain and Horner syndrome due to brachial plexus involvement.

Many patients present with symptoms caused by distant metastases involving the brain, bones, liver, or adrenal glands. Early detection through imaging significantly improves survival.

16. Describe the importance of histologic type and clinical stage in the prognosis and therapy of patients with lung cancer.

Histological classification determines the biological behavior and treatment strategy of lung cancer. Small cell carcinoma is highly aggressive and is treated mainly with chemotherapy and radiotherapy because surgery is rarely beneficial.

Non-small cell carcinomas are managed primarily by surgical resection when localized. Clinical staging using the TNM system is the most important prognostic factor. Early-stage tumors have significantly better survival than advanced metastatic disease.

Molecular testing identifies patients suitable for targeted therapies such as EGFR or ALK inhibitors. Immunotherapy has improved outcomes in selected advanced tumors.

Histological type predicts response to specific treatments. Accurate staging and pathological diagnosis are essential for individualized management and prognosis.

---

17. What are the most frequent paraneoplastic syndromes in patients with lung cancer?

Paraneoplastic syndromes result from ectopic hormone production or immune-mediated mechanisms rather than direct tumor invasion. Small cell carcinoma commonly produces ACTH, causing Cushing syndrome, and ADH, causing syndrome of inappropriate antidiuretic hormone secretion (SIADH).

Squamous cell carcinoma frequently secretes parathyroid hormone-related peptide (PTHrP), resulting in hypercalcemia. Neurological syndromes include Lambert-Eaton myasthenic syndrome and peripheral neuropathy.

Hypertrophic pulmonary osteoarthropathy and digital clubbing are well-recognized manifestations. Hypercoagulability may lead to migratory thrombophlebitis. Dermatomyositis and polymyositis occur occasionally.

Recognition of paraneoplastic syndromes may facilitate early diagnosis of occult lung cancer. Successful treatment of the primary tumor often improves these manifestations.

18. List the main histologic subtypes of neuroendocrine tumors of the lungs.

Pulmonary neuroendocrine tumors are classified into four major histological subtypes based on differentiation and biological behavior. Typical carcinoid tumor is a low-grade neuroendocrine neoplasm with an excellent prognosis. 

Atypical carcinoid tumor is an intermediate-grade tumor with increased mitotic activity and focal necrosis. Large cell neuroendocrine carcinoma is a high-grade malignant tumor with aggressive clinical behavior. Small cell carcinoma is the most aggressive neuroendocrine carcinoma and metastasizes early.

All neuroendocrine tumors express markers such as chromogranin, synaptophysin, and CD56. Prognosis worsens progressively from typical carcinoid to small cell carcinoma. Histological grading guides treatment and predicts survival.

19. What are the main clinical and pathologic characteristics of bronchial carcinoids?

Bronchial carcinoids are well-differentiated neuroendocrine tumors arising from Kulchitsky cells of the bronchial mucosa. They account for a small proportion of primary lung tumors and usually occur in younger patients.

Most tumors arise centrally within the major bronchi and produce cough, wheezing, recurrent pneumonia, or hemoptysis because of bronchial obstruction. Grossly, they appear as well-circumscribed, highly vascular, polypoid masses projecting into the bronchial lumen. Microscopically, uniform neuroendocrine cells are arranged in nests, trabeculae, or rosettes.

Typical carcinoids have few mitoses and no necrosis, whereas atypical carcinoids show increased mitotic activity and focal necrosis. Carcinoid syndrome is uncommon because vasoactive substances are usually metabolized in the lungs. Surgical excision is the treatment of choice.

The prognosis is excellent for typical carcinoids and intermediate for atypical carcinoids.

20. List the usual features of metastatic tumors in the lungs.

 

The lungs are one of the most common sites of metastatic spread because they receive the entire cardiac output through the pulmonary circulation. Metastases commonly arise from cancers of the breast, colon, kidney, thyroid, prostate, liver, and malignant melanoma.

Grossly, metastatic tumors usually appear as multiple, well-circumscribed, rounded nodules of varying sizes scattered throughout both lungs. Some tumors produce diffuse lymphangitic spread or pleural involvement.

Histologically, the metastatic tumor resembles the primary malignancy. Patients may be asymptomatic or present with cough, dyspnea, chest pain, or hemoptysis. Chest CT is highly sensitive for detecting pulmonary metastases.

Treatment depends on the primary tumor, extent of metastasis, and patient's clinical condition. Pulmonary metastases generally indicate advanced-stage malignancy and carry a guarded prognosis.

---

DR.C.GANESAN M.D

PROFESSOR OF MEDICINE

 

SPECIAL SELECTED TOPICS- RESPIRATORY SYSTEM DISORDERS-SSTRSDO-QAA 013

1. Describe the main pathologic characteristics of diffuse interstitial lung disease and classify it according to etiology.

Diffuse interstitial lung diseases are characterized by chronic inflammation and fibrosis involving the pulmonary interstitium and alveolar walls. They reduce lung compliance and impair gas exchange. Histologically, there is varying degrees of interstitial inflammation, fibroblast proliferation, and collagen deposition.

Advanced disease results in honeycomb lung due to cystic fibrotic spaces. Etiologically, they are classified into idiopathic interstitial pneumonias, occupational lung diseases, drug-induced lung disease, connective tissue disease-associated disorders, hypersensitivity pneumonitis, and granulomatous diseases such as sarcoidosis.

Idiopathic pulmonary fibrosis is the most common type. Progressive fibrosis causes restrictive lung disease.

Pulmonary hypertension may develop in advanced cases. Respiratory failure is the major cause of death.

2. What are the morphologic manifestations of diffuse interstitial disease of the lung?

The lungs become firm, stiff, and reduced in compliance because of widespread fibrosis. Gross examination shows diffuse scarring, particularly in the lower lobes in many forms of disease. Microscopically, the alveolar septa are thickened by chronic inflammatory cells and collagen deposition.

Fibroblast proliferation contributes to progressive fibrosis. Type II pneumocyte hyperplasia is often present during repair. Advanced disease produces honeycomb lung with multiple cystic airspaces lined by bronchiolar epithelium.

Pulmonary vessels may show medial hypertrophy due to pulmonary hypertension. Gas exchange is impaired because of increased diffusion distance.

Progressive fibrosis eventually causes respiratory insufficiency. The severity depends on the extent and duration of interstitial damage.

---

DR.C.GANESAN M.D

PROFESSOR OF MEDICINE

 

SPECIAL SELECTED TOPICS- RESPIRATORY SYSTEM DISORDERS-SSTRSDO-QAA 011

1. What is the difference between bronchopneumonia and lobar pneumonia?

Bronchopneumonia is a patchy, multifocal bacterial infection centered on bronchioles and adjacent alveoli. It commonly affects infants, elderly individuals, and debilitated patients. Multiple foci of consolidation are scattered throughout one or more lobes, often involving both lungs.

Lobar pneumonia, in contrast, involves uniform consolidation of an entire lobe or a large portion of it. It is classically caused by Streptococcus pneumoniae. Bronchopneumonia is usually caused by organisms such as Staphylococcus aureus, Haemophilus influenzae, or gram-negative bacteria.

Lobar pneumonia progresses through well-defined pathological stages. Bronchopneumonia has a more irregular distribution and variable progression.

Both conditions impair gas exchange and may lead to respiratory failure if severe.

2. List the defense mechanisms that protect against bacterial pneumonia.

The respiratory tract possesses several defense mechanisms that prevent bacterial infection. The nasal passages filter inhaled particles. The mucociliary escalator removes microorganisms trapped in mucus. Cough and sneeze reflexes expel foreign material from the airways. Alveolar macrophages phagocytose inhaled bacteria reaching the alveoli.

Secretory IgA antibodies protect the respiratory mucosa. Complement proteins and neutrophils participate in bacterial killing. Surfactant proteins also contribute to innate immune defense. Normal respiratory flora inhibit colonization by pathogenic organisms.

Intact immunity and effective airway clearance are essential for preventing bacterial pneumonia.

3. Name the four classical stages of lobar pneumonia.

Lobar pneumonia classically progresses through four pathological stages. The first stage is congestion, occurring during the initial 24 hours, characterized by vascular engorgement and edema. The second stage is red hepatization, in which alveoli become filled with red blood cells, neutrophils, and fibrin, giving the lung a liver-like consistency.

The third stage is gray hepatization, during which red blood cells disintegrate while fibrin and leukocytes remain abundant. The fourth stage is resolution, where enzymatic digestion removes the exudate and normal lung architecture is restored.

Macrophages play a major role during resolution. Complete recovery usually occurs if treatment is prompt. Delayed resolution may lead to complications such as abscess formation or fibrosis.

4. Name the main pathologic characteristics of primary atypical pneumonia.

Primary atypical pneumonia is usually caused by viruses, Mycoplasma pneumoniae, Chlamydia, or other atypical organisms. The infection primarily affects the alveolar septa rather than filling alveolar spaces with exudate.

Grossly, the lungs show patchy areas of congestion without extensive consolidation. Microscopically, the interstitium contains mononuclear inflammatory cells, mainly lymphocytes and macrophages. The alveolar walls become thickened because of inflammatory infiltration.

Alveolar spaces contain little or no purulent exudate. Hyaline membranes may develop in severe viral infections.

Symptoms are often milder than in typical bacterial pneumonia despite widespread radiological changes. Most patients recover completely with appropriate treatment.

5. What are the most frequent conditions that predispose to the formation of pulmonary abscess?

Pulmonary abscess is a localized area of suppurative necrosis within the lung producing a cavity filled with pus. Aspiration of oropharyngeal secretions is the commonest predisposing factor, particularly in unconscious or alcoholic patients.

Necrotizing bacterial pneumonia may also lead to abscess formation. Bronchial obstruction caused by tumors or foreign bodies predisposes to secondary infection. Septic emboli from infective endocarditis can produce multiple lung abscesses. Tuberculosis and fungal infections occasionally result in cavitary lesions. Immunocompromised patients are at increased risk. Poor oral hygiene increases aspiration of anaerobic bacteria.

Untreated abscesses may rupture into the pleural cavity or bloodstream, causing serious complications.

---

DR.C.GANESAN M.D

PROFESSOR OF MEDICINE

 

SPECIAL SELECTED TOPICS- RESPIRATORY SYSTEM DISORDERS-SSTRSDO-QAA 010

1. What is the meaning of the term bronchiectasis and how does it manifest clinically?

Bronchiectasis is the permanent abnormal dilatation of bronchi and bronchioles caused by destruction of the bronchial wall due to chronic infection and inflammation. It usually develops after repeated respiratory infections or bronchial obstruction.

 The damaged airways lose their elastic and muscular support. Patients present with chronic productive cough and large amounts of foul-smelling purulent sputum. Recurrent episodes of fever and chest infections are common.

Hemoptysis may occur due to erosion of bronchial blood vessels. Dyspnea and wheezing develop in advanced disease. Clubbing of fingers is seen in long-standing cases.

Pulmonary function gradually deteriorates if untreated. High-resolution CT is the investigation of choice for diagnosis.

2. What are the most frequent conditions associated with bronchiectasis?

 

Bronchiectasis commonly follows severe bacterial pneumonia, tuberculosis, or recurrent childhood respiratory infections. Bronchial obstruction by tumors, foreign bodies, or mucus plugs predisposes to localized bronchiectasis.

Congenital disorders such as cystic fibrosis are important causes. Primary ciliary dyskinesia, including Kartagener syndrome, impairs mucociliary clearance. Immunodeficiency disorders increase susceptibility to recurrent infections.

Allergic bronchopulmonary aspergillosis is another recognized cause. Chronic aspiration due to neurological disorders may contribute. Airway obstruction and persistent infection work together to destroy bronchial walls.

These conditions lead to irreversible bronchial dilatation. Early treatment of underlying diseases reduces the risk of bronchiectasis.

3. What is the triad of Kartagener syndrome?

 

Kartagener syndrome is a subtype of primary ciliary dyskinesia caused by inherited defects in ciliary structure and function. The classical triad consists of bronchiectasis, chronic sinusitis, and situs inversus. Defective ciliary movement prevents normal clearance of respiratory secretions. Recurrent respiratory infections lead to progressive bronchiectasis.

Chronic sinusitis causes persistent nasal congestion and discharge. Situs inversus results from abnormal embryonic organ rotation. Male infertility is common because sperm flagella are also immotile. Female fertility may also be reduced due to impaired fallopian tube ciliary function.

Diagnosis is confirmed by ciliary ultrastructural studies or genetic testing. Management focuses on preventing respiratory infections and preserving lung function.

4. Describe the major morphologic characteristics of bronchiectasis on gross inspection.

Grossly, the affected bronchi are permanently dilated and may extend almost to the pleural surface. The dilated bronchi contain thick purulent secretions.

The bronchial walls appear thickened, inflamed, and ulcerated. Depending on severity, the bronchi may be cylindrical, varicose, or cystic in appearance. Surrounding lung tissue often shows fibrosis and collapse.

The lower lobes are most commonly involved. Severe cases demonstrate multiple cyst-like dilatations filled with pus. Pleural fibrosis may accompany long-standing disease.

Microscopy reveals chronic inflammatory infiltrates and destruction of cartilage, smooth muscle, and elastic tissue. These irreversible structural changes account for persistent airway dysfunction.

---

DR.C.GANESAN M.D

PROFESSOR OF MEDICINE

 

SPECIAL SELECTED TOPICS- RESPIRATORY SYSTEM DISORDERS-SSTRSDO-QAA 009

1. Define bronchial asthma and status asthmaticus.

Bronchial asthma is a chronic inflammatory disorder of the airways characterized by reversible bronchoconstriction, airway hyperresponsiveness, and increased mucus production.

Airflow obstruction is usually episodic and reversible either spontaneously or with treatment. Patients present with recurrent wheezing, cough, chest tightness, and breathlessness. Inflammation involves eosinophils, mast cells, lymphocytes, and airway epithelium.

Status asthmaticus is a severe, prolonged asthma attack that does not respond adequately to standard bronchodilator therapy. It causes persistent bronchospasm and severe airflow obstruction.

Patients develop profound hypoxemia and respiratory distress. Carbon dioxide retention indicates impending respiratory failure. Status asthmaticus is a medical emergency requiring immediate intensive treatment.

2. What are the main differences between extrinsic and intrinsic asthma?

Extrinsic asthma, also called atopic asthma, is mediated by IgE-dependent hypersensitivity reactions to environmental allergens. It commonly begins during childhood and is often associated with a personal or family history of allergy. Common allergens include pollen, dust mites, animal dander, and foods.

Intrinsic asthma is not associated with specific allergens or IgE-mediated reactions. It usually develops in adults after respiratory infections, stress, exercise, cold air, or exposure to irritants.

Skin allergy tests are positive in extrinsic asthma but usually negative in intrinsic asthma. Serum IgE levels are elevated in atopic asthma.

Both forms produce reversible airway obstruction and similar pathological changes. Clinical management is largely similar despite different initiating mechanisms.

3. What is the pathogenesis of atopic asthma?

Atopic asthma begins with sensitization to inhaled allergens in genetically susceptible individuals. Allergen exposure stimulates helper T lymphocytes to promote IgE production by B cells. IgE binds to mast cells present in the airway mucosa.

Re-exposure to the allergen causes cross-linking of IgE and mast cell degranulation. Histamine, leukotrienes, prostaglandins, and other mediators produce immediate bronchoconstriction. These mediators also increase vascular permeability and mucus secretion.

Eosinophils are recruited and release toxic proteins that damage airway epithelium. Chronic inflammation leads to airway remodeling with smooth muscle hypertrophy and subepithelial fibrosis.

Airway hyperresponsiveness persists even between acute attacks. The result is recurrent episodes of reversible airflow obstruction.

4. Describe the main differences between the acute and late-phase reactions in patients with bronchial asthma.

The acute phase begins within minutes after allergen exposure and is mediated primarily by mast cell degranulation. Histamine, leukotrienes, and prostaglandins cause immediate bronchospasm, edema, and mucus secretion.

Symptoms include sudden wheezing, cough, and breathlessness. The late-phase reaction develops approximately 4–8 hours later. It is characterized by infiltration of eosinophils, neutrophils, lymphocytes, and macrophages into the airway wall.

 These inflammatory cells release cytokines and toxic proteins that sustain airway inflammation. Airway edema and epithelial damage become more pronounced. Bronchial hyperresponsiveness increases during the late phase.

Repeated late-phase reactions contribute to chronic airway remodeling and persistent asthma.

5. What are the major mediators responsible for bronchospasm in patients with bronchial asthma?

Histamine released from mast cells is an important early mediator causing bronchoconstriction. Leukotrienes C4, D4, and E4 are among the most potent bronchoconstrictors and also increase vascular permeability. Prostaglandin D2 contributes to bronchospasm and vasodilation. Platelet-activating factor promotes inflammation and airway narrowing.

Cytokines such as IL-4, IL-5, and IL-13 stimulate IgE production and eosinophilic inflammation. Eosinophils release major basic protein and eosinophil cationic protein, damaging airway epithelium. Chemokines recruit additional inflammatory cells into the bronchi.

Acetylcholine released through parasympathetic pathways further enhances bronchoconstriction. Together these mediators produce airway hyperresponsiveness and recurrent asthma attacks.

6. What are the main pathologic characteristics of bronchial asthma?

The lungs are usually overexpanded because of air trapping during acute attacks. Bronchi and bronchioles are obstructed by thick mucus plugs. Mucus plugs contain Curschmann spirals and Charcot-Leyden crystals derived from eosinophils.

The bronchial mucosa is edematous and infiltrated by eosinophils, mast cells, and lymphocytes. Goblet cell hyperplasia causes excessive mucus production. The basement membrane becomes thickened because of subepithelial fibrosis. Smooth muscle hypertrophy contributes to airway narrowing.

Chronic inflammation produces airway remodelling and persistent hyperresponsiveness. Although airflow obstruction is usually reversible, long-standing disease may lead to partially irreversible changes.

These pathological findings explain the recurrent episodes of wheezing and dyspnea.

7. Discuss the clinical characteristics and prognosis of patients with bronchial asthma.

Bronchial asthma presents with recurrent episodes of wheezing, breathlessness, chest tightness, and cough, particularly at night or early morning. Symptoms are often triggered by allergens, exercise, infections, cold air, or irritants. Airflow obstruction is usually reversible with bronchodilator therapy. Pulmonary function tests demonstrate variable airflow limitation.

Most patients achieve good symptom control with inhaled corticosteroids and bronchodilators. Acute severe attacks may progress to status asthmaticus requiring emergency treatment. Repeated uncontrolled attacks can lead to airway remodeling and persistent airflow limitation.

Mortality is low with appropriate management but increases in severe uncontrolled asthma. Avoidance of triggers and adherence to long-term therapy significantly improve prognosis.

Early diagnosis and regular follow-up help maintain normal lung function and quality of life.

---

DR.C.GANESAN M.D

PROFESSOR OF MEDICINE